WINSUNBIO
839729
HIGO
872351
DRIVE
838275
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | -20.00%431.85M | -51.87%242.04M | -78.55%87.47M | -81.20%586.12M | -78.48%539.82M | -70.29%502.86M | -57.03%407.72M | 10.85%3.12B | 45.52%2.51B | 55.07%1.69B |
Refunds of taxes and levies | 13.27%20.88M | -26.78%13.5M | -22.41%10.3M | -87.03%20.43M | -85.89%18.44M | -81.21%18.44M | -76.12%13.28M | -10.91%157.61M | 15.70%130.69M | 32.20%98.14M |
Net deposit increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in borrowings from central bank | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in placements from other financial institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received from interests, fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in repurchase business capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Premiums received from original insurance contracts | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net cash received from reinsurance business | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in deposits from policyholders | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net increase in funds disbursed | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net cash received from trading securities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received relating to other operating activities | -7.41%79.09M | -17.80%55.52M | -60.16%17.95M | 60.98%90.73M | 135.08%85.42M | 120.24%67.54M | 204.76%45.07M | 677.78%56.36M | 376.20%36.34M | 740.95%30.67M |
Cash inflows from operating activities | -17.38%531.82M | -47.17%311.06M | -75.17%115.73M | -79.07%697.29M | -75.94%643.68M | -67.67%588.83M | -54.27%466.06M | 11.18%3.33B | 45.06%2.67B | 55.76%1.82B |
Goods services cash paid | -35.27%386.56M | -44.18%257.03M | -56.03%122.95M | -71.20%647.93M | -68.41%597.15M | -66.61%460.44M | -62.16%279.6M | -7.25%2.25B | 12.68%1.89B | 32.55%1.38B |
Staff behalf paid | -5.09%72.72M | -21.44%46.11M | -33.31%25.5M | -51.30%97.88M | -50.80%76.62M | -48.21%58.7M | -40.48%38.23M | -18.62%200.98M | -12.06%155.72M | -2.08%113.35M |
All taxes paid | -69.59%4.5M | -81.45%3M | -45.07%5.42M | -47.38%17.47M | -42.00%14.79M | 125.94%16.15M | 780.54%9.87M | 348.74%33.19M | 278.42%25.5M | 39.99%7.15M |
Net loan and advance increase | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net deposit in central bank and institutions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Net lend capital | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid for fees and commissions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid for indemnity of original insurance contract | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Policy dividend cash paid | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid relating to other operating activities | 74.34%74.81M | 34.53%48.88M | 12.01%22.92M | -72.10%64.94M | -78.34%42.91M | -73.77%36.34M | -73.91%20.47M | 9.11%232.71M | 37.15%198.09M | 33.05%138.53M |
Cash outflows from operating activities | -26.37%538.59M | -37.89%355.03M | -49.22%176.79M | -69.52%828.21M | -67.77%731.47M | -65.10%571.62M | -60.56%348.17M | -6.11%2.72B | 13.15%2.27B | 29.45%1.64B |
Net cash flows from operating activities | 92.29%-6.77M | -355.37%-43.97M | -151.80%-61.06M | -121.32%-130.92M | -121.66%-87.79M | -90.60%17.22M | -13.56%117.89M | 498.91%614.19M | 350.65%405.39M | 290.64%183.24M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 308.08%3.35B | 220.27%1.88B | 86.54%800M | 1,148.86%717.52M | --821.16M | --587M | --428.86M | 474.54%57.45M | ---- | ---- |
Cash received from returns on investments | -45.24%7.27M | -67.68%3.39M | -93.66%528.96K | 604.39%8.8M | 950.82%13.29M | 923.52%10.48M | 2,607.56%8.35M | -78.58%1.25M | -80.67%1.26M | -79.30%1.02M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -90.37%299.5K | -89.63%299.5K | ---- | 2,531.51%26.82M | 32.81%3.11M | 383.09%2.89M | 130.07%1.2M | -20.04%1.02M | 87.45%2.34M | -39.53%598K |
Net cash received from disposal of subsidiaries and other business units | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash received relating to other investing activities | -94.60%78.4K | -95.97%58.6K | -75.96%26.2K | -91.54%416.99K | -88.52%1.45M | -76.44%1.45M | -98.02%109K | -98.01%4.93M | -94.10%12.65M | -96.42%6.17M |
Cash inflows from investing activities | 300.31%3.36B | 213.00%1.88B | 82.56%800.56M | 1,065.54%753.55M | 5,060.58%839.01M | 7,628.12%601.83M | 6,835.02%438.52M | -75.55%64.65M | -93.00%16.26M | -95.86%7.79M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 90.88%219.55M | 289.98%175.77M | 9.66%31.23M | -44.58%106.12M | -7.97%115.02M | -51.61%45.07M | -21.46%28.48M | -16.22%191.46M | -40.59%124.98M | -48.05%93.14M |
Cash paid to acquire investments | 947.84%4.12B | 848.45%2.41B | 1,389.20%927.56M | -54.28%253.38M | --392.91M | --254.1M | --62.29M | 6,384.57%554.23M | ---- | ---- |
Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | --22.67M | ---- | ---- | ---- | --0 | ---- | ---- |
Impawned loan net increase | ---- | --0 | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
Cash paid relating to other investing activities | -92.44%228.8K | 238.84%227.7K | -94.47%1.49K | 278.76%14.45M | -58.97%3.03M | -99.05%67.2K | -99.13%27K | -96.15%3.82M | -92.59%7.37M | -6.11%7.08M |
Cash outflows from investing activities | 748.77%4.34B | 764.19%2.59B | 956.01%958.79M | -47.08%396.62M | 286.05%510.96M | 198.60%299.24M | 130.56%90.79M | 122.96%749.51M | -58.02%132.36M | -47.86%100.21M |
Net cash flows from investing activities | -398.19%-978.21M | -332.08%-702.25M | -145.51%-158.24M | 152.12%356.93M | 382.56%328.05M | 427.39%302.59M | 1,151.89%347.73M | -854.08%-684.86M | -39.54%-116.1M | -2,176.53%-92.43M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --1.89B | ---- | ---- |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash from borrowing | 100.00%100K | 0.00%50K | ---- | -99.99%50K | -99.99%50K | -99.99%50K | ---- | -10.99%719.49M | 51.65%722.54M | 64.68%516.75M |
Cash received relating to other financing activities | ---- | ---- | ---- | --0 | ---- | ---- | ---- | -86.80%9.64M | -88.11%8.68M | -88.09%8.68M |
Cash inflows from financing activities | 100.00%100K | 0.00%50K | ---- | -100.00%50K | -99.99%50K | -99.99%50K | ---- | 197.18%2.62B | 33.07%731.22M | 35.88%525.44M |
Borrowing repayment | -99.97%50K | ---- | ---- | -86.36%159.11M | -83.52%159.09M | -71.14%159.11M | -31.49%158.63M | 83.81%1.17B | 112.40%965.52M | 55.95%551.31M |
Dividend interest payment | -100.00%377.01 | ---- | ---- | 1,070.11%150.94M | 1,026.95%153.77M | 1,431.62%143.63M | -56.70%2.62M | -76.13%12.9M | -72.11%13.64M | -78.82%9.38M |
-Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Cash payments relating to other financing activities | ---- | ---- | ---- | -98.37%1.94M | -92.47%502.09K | -91.58%502.31K | ---- | 178.89%119.62M | -81.53%6.67M | -83.00%5.97M |
Cash outflows from financing activities | -99.98%50.38K | --0 | ---- | -75.99%311.99M | -68.21%313.36M | -46.49%303.25M | -33.50%161.26M | 77.57%1.3B | 82.70%985.84M | 30.90%566.66M |
Net cash flows from financing activities | 100.02%49.62K | 100.02%50K | ---- | -123.63%-311.94M | -23.05%-313.31M | -635.52%-303.2M | -2,199.31%-161.26M | 781.78%1.32B | -2,668.92%-254.61M | 10.77%-41.22M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | -101.83%-53.21K | -172.79%-6.87M | 97.13%-287.88K | -91.96%4.21M | -93.52%2.9M | -69.67%9.44M | -168.11%-10.04M | 554.90%52.41M | 1,100.36%44.78M | 538.62%31.12M |
Net increase in cash and cash equivalents | -1,304.05%-984.98M | -2,990.55%-753.04M | -174.61%-219.59M | -106.28%-81.72M | -188.29%-70.15M | -67.72%26.05M | 217.96%294.32M | 670.52%1.3B | 133.18%79.46M | 152.59%80.71M |
Add:Begin period cash and cash equivalents | -4.22%1.86B | -4.22%1.86B | -4.22%1.86B | 204.82%1.94B | 204.82%1.94B | 204.82%1.94B | 204.82%1.94B | 36.21%635.54M | 36.21%635.54M | 36.21%635.54M |
End period cash equivalent | -53.37%870.53M | -43.85%1.1B | -26.69%1.64B | -4.22%1.86B | 161.13%1.87B | 174.11%1.96B | 206.49%2.23B | 204.82%1.94B | 214.84%714.99M | 128.74%716.25M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.